Company / Cash per Share
Collegium Pharmaceutical, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$7.29
FY2025
5-year range
$2.24 / $7.50
FY2021-FY2025
Trend
+225.0%
vs FY2024
Sector context
#27 of 204
Health Care
What the data says
Cash per Share changed +225% YoY in FY2025, a notable deviation from the 9-year average annual change of +20%.
Based on SEC 10-K filings.
7.29 in FY2025 with a 5-year CAGR of +7.7%. Top quartile in the Health Care sector.
Declined from $7.50 to $7.29 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 204This company $7.29 Sector average $73.19
▼
-90.0% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 225.0% year-over-year.
- Ranks #27 out of 204 companies in the Health Care sector.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.29 | +225.0% |
| FY2024 | $2.24 | -70.1% |
| FY2023 | $7.50 | +46.1% |
| FY2022 | $5.13 | -7.4% |
| FY2021 | $5.54 | +10.1% |
| FY2020 | $5.03 | -1.6% |
| FY2019 | $5.11 | +14.2% |
| FY2018 | $4.47 | +10.7% |
| FY2017 | $4.04 | -45.3% |
| FY2016 | $7.39 | +4.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026